Biperiden effects and plasma levels in volunteers
- 1 January 1984
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 27 (5) , 619-621
- https://doi.org/10.1007/bf00556903
Abstract
The pharmacokinetics of biperiden was studied and compared with pharmacodynamics (pupil size, accomodation, self-rating mood scale) in 6 healthy volunteers. A single-blind cross-over design was employed with placebo and biperiden (4 mg as commercially available tablets). After a lag time of 0.5 h, biperiden was rapidly absorbed with a half-life of 0.3 h, plasma peak levels of 5 ng/ml being reached after 1.5 h. Biperiden showed good tissue penetration (distribution half-life 0.6 h; ratio of total to central distribution volume 9.6), the terminal half-life time of plasma concentration was 18 h, and the oral clearance was 146 l/h. The pharmacodynamic maximum lagged behind the plasma peak concentration by 1 (self-rating) to 4 h (accommodation).Keywords
This publication has 7 references indexed in Scilit:
- Sodium vaiproate and biperiden in neuroleptic‐induced akathisia, parkinsonism and hyperkinesiaActa Psychiatrica Scandinavica, 1983
- [Pupillometry, a clinical pharmacological model / Relevance and limits (author's transl)].1982
- Determination of biperiden in human serum by glass capillary gas chromatography with isothermal splitless injection and nitrogen-sensitive detectionJournal of Chromatography B: Biomedical Sciences and Applications, 1981
- Die Parkinson-KrankheitPublished by Springer Nature ,1980
- [Metabolism of antiparkinson drugs. An example of competitive hydroxylation].1979
- [Pupillometric studies in the practical use of psychopharmaca].1967